HMOX1 and lymphoma: Since this occurs in a p38 MAPK–HO-1-dependent manner, inhibition of p38 MAPK or upregulation of HO-1 by small-molecule activators would have a beneficial effect on preventing expansion and systemic spread of leukemia/lymphoma cells when the ComC becomes activated [31].